Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Artiva Biotherapeutics, Inc. - Common Stock (NQ:ARTV)

3.770 -0.400 (-9.59%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 328,248
Open 4.160
Bid (Size) 3.880 (3,700)
Ask (Size) 3.980 (100)
Prev. Close 4.170
Today's Range 3.750 - 4.245
52wk Range 1.470 - 15.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-62.2%
-62.2%
1 Month
+27.8%
+27.8%
3 Month
+25.2%
+25.2%
6 Month
+70.6%
+70.6%
1 Year
-66.3%
-66.3%

More News

Read More
4 Biotech Stocks Lifting Off As Momentum Builds
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top movers analysis in the middle of the day on 2025-10-20: top gainers and losers in today's session.
Via Chartmill
Why Is Artiva Up Today?
Via Benzinga
Top movers in Friday's session
Via Chartmill
Friday's session: most active stocks
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
In today's session, these stocks are experiencing unusual volume.
Via Chartmill
Top stock movements in today's session.
Via Chartmill
Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings
Via Benzinga
Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally
Via Stocktwits
Which stocks are gapping on Friday?
Via Chartmill
Dow Gains Over 100 Points; American Express Increases 2025 Forecast
Via Benzinga
Topics Stocks
Discover the top movers in Friday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
Via Chartmill
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire
Artiva (ARTV) Q2 Loss Widens 19.7%
Via The Motley Fool
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights
From Artiva Biotherapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Artiva Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, Artiva Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Artiva Biotherapeutics, Inc. - Common Stock trade on?
Artiva Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Artiva Biotherapeutics, Inc. - Common Stock?
The ticker symbol for Artiva Biotherapeutics, Inc. - Common Stock is ARTV on the Nasdaq Stock Market
What is the current price of Artiva Biotherapeutics, Inc. - Common Stock?
The current price of Artiva Biotherapeutics, Inc. - Common Stock is 3.770
When was Artiva Biotherapeutics, Inc. - Common Stock last traded?
The last trade of Artiva Biotherapeutics, Inc. - Common Stock was at 11/03/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.